Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects

Clinical Pharmacokinetics - United Kingdom
doi 10.1007/s40262-018-0700-3
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Influence of CYP2C9 and CYP2C19 Genetic Polymorphisms on Pharmacokinetics of Gliclazide MR in Chinese Subjects

British Journal of Clinical Pharmacology
Pharmacology
2007English

Pharmacokinetics of 18f-Labeled Fluconazole in Healthy Human Subjects by Positron Emission Tomography.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1993English

The Effect of Ciprofloxacin on Theophylline Pharmacokinetics in Healthy Subjects.

British Journal of Clinical Pharmacology
Pharmacology
1995English

Coadministration of Gemfibrozil and Itraconazole Has Only a Minor Effect on the Pharmacokinetics of the CYP2C9 and CYP3A4 Substrate Nateglinide

British Journal of Clinical Pharmacology
Pharmacology
2005English

Effect of Multiple Oral Dosing of Fluconazole on the Pharmacokinetics of Cyclosporine in Healthy Beagles

Journal of Veterinary Medical Science
Veterinary
2008English

Effect of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Zolpidem in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2007English

Effect of MDR1 C3435T Polymorphism on Lansoprazole in Healthy Japanese Subjects

European Journal of Clinical Pharmacology
MedicinePharmacology
2009English

The Effect of Apixaban on the Pharmacokinetics of Digoxin and Atenolol in Healthy Subjects

Clinical Pharmacology: Advances and Applications
Pharmacology
2017English

The Effect of Bosentan on the Pharmacokinetics of Digoxin in Healthy Male Subjects

British Journal of Clinical Pharmacology
Pharmacology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy